Article Versions Notes

Cavallieri F, Lucchi C, Grisanti S, Monfrini E, Fioravanti V, Toschi G, Di Rauso G, Rossi J, Di Fonzo A, Biagini G, et al. Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype? Biomolecules. 2024; 14(8):1022. https://doi.org/10.3390/biom14081022

Cavallieri, Francesco, Chiara Lucchi, Sara Grisanti, Edoardo Monfrini, Valentina Fioravanti, Giulia Toschi, Giulia Di Rauso, Jessica Rossi, Alessio Di Fonzo, Giuseppe Biagini, and et al. 2024. "Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype?" Biomolecules 14, no. 8: 1022. https://doi.org/10.3390/biom14081022

Cavallieri, F., Lucchi, C., Grisanti, S., Monfrini, E., Fioravanti, V., Toschi, G., Di Rauso, G., Rossi, J., Di Fonzo, A., Biagini, G., & Valzania, F. (2024). Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype? Biomolecules, 14(8), 1022. https://doi.org/10.3390/biom14081022